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Abstract
Autoimmune bullous diseases are a group of rare, chronic blistering diseases that 
affects the skin and mucous membranes. Mucous membrane pemphigoid (MMP) 
is the most frequently occurring autoimmune bullous disease in the oral cavity, 
followed by pemphigus vulgaris (PV). Early diagnosis of MMP or PV is critical for 
proper management and prevention of potential serious complications. This study 
was based on a retrospective review of 39 cases that were classified as MMP (25 
patients) or PV (14 patients). Nikolsky’s sign characterized by epithelial detach-
ment as a result of slight pressure or rubbing the oral mucosa is a simple test that 
can confirm the existence of gingival desquamation. A positive reaction was con-
firmed in 38 patients (97.4%) at their first visit. This result indicates that patients 
showing positive Nikolsky’s sign should include MMP or PV in the differential 
diagnosis and, in that case, histopathological examination and direct immunofluo-
rescence testing are critical to establish the final diagnosis. For the early diagnosis of 
autoimmune bullous disorders, oral healthcare providers should consider the use of 
the test for Nikolsky’s sign that may ultimately lead to the early diagnosis of MMP 
and PV or other diseases or disorders.
Keywords: gingival diseases, pemphigoid benign mucous membrane, pemphigus, 
oral medicine, autoimmune diseases
1. Introduction
Autoimmune bullous diseases are a group of rare, chronic blistering diseases 
that affect the skin and mucous membranes. Mucous membrane pemphigoid 
(MMP) is the most frequently occurring autoimmune bullous disease in the oral 
cavity, followed by pemphigus vulgaris (PV) [1–3]. Other diseases include bullous 
pemphigoid, lichen planus pemphigoides, paraneoplastic pemphigus, and chronic 
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ulcerative stomatitis [4, 5]. The primary lesions of MMP or PV often develop in 
the oral cavity, and patients may complain of oral symptoms and visit their dental 
clinic first before seeking medical consultation [6, 7]. Therefore, oral healthcare 
providers need to have some current knowledge about autoimmune bullous diseases 
and have a great responsibility to achieve early detection, diagnosis, and treatment 
of the diseases or to refer the patients to other medical or dental specialists as soon 
as possible.
The gingiva is one of the target tissues of autoimmune bullous diseases. Patients 
often complain of uncomfortable or painful gingiva or other oral pathologic tissues 
and usually seek care from their general dentist or periodontist. Desquamative 
gingivitis (DG) characterized by gingival desquamation, erosion, ulceration, 
erythematous gingiva, and hemorrhage is a clinical term used to describe some 
pathologic changes that are common to a variety of gingival diseases or disorders 
[1–3, 8, 9]. Table 1 summarizes the clinical appearance of DG. It is important to 
remember that DG is a general descriptive term rather than a diagnosis (Table 2). 
Therefore, diagnosis of the specific disease or disorder causing DG is important to 
provide proper treatment. Biopsy evaluation is often required for definitive diag-
nosis. Especially, histopathological examination and direct immunofluorescence 
(DIF) testing are critical to establish the final diagnosis for MMP or PV [3, 10–12].
MMP is a group of rare, autoimmune bullous disease that can primarily affect 
mucous membranes. Various components in the basement membrane zone (BMZ) 
have been recognized as the target antigens of MMP [13–16]. The major autoanti-
gens in MMP are BP180 C-terminal domain and laminin-332 [15, 16]. In more than 
90% of MMP patients, lesions are found in the oral mucosa [14, 17, 18]. DG lesions 
are usually present. Most MMP patients are in their fifth decade of life, and majority 
of them are females [13, 14, 17, 18]. Scar formation and an associated loss of func-
tion are the most serious complications of some forms of MMP. Sight-threatening 
ocular scarring and life-threatening airway obstruction have been reported 
although the scarring is rarely seen in the oral mucosa [17, 19–22]. Early diagnosis of 
MMP is critical, and immunosuppressive therapy may prevent scarring in mucous 
membranes. Histopathologically, subepithelial blister formation is characteristic, 
but it is not always seen in biopsy specimens [3, 10, 12, 13]. However, this is a 
nondiagnostic finding since it is also found in other vesiculobullous diseases. In DIF 
testing, a linear pattern of C3, IgG, or other immunoglobulin, fibrin, or fibrinogen 
is present along the BMZ [3, 10, 12, 13].
PV is a rare, autoimmune bullous disease that is characterized by intraepithelial 
acantholysis. PV can develop at any age but most commonly occurs in middle-aged and 
elderly patients [2, 23, 24]. PV affects both males and females equally [2, 23, 24]. PV 
is a rare, but serious and potentially life-threatening condition if left untreated [25]. 
Oral lesions are the first site of PV involvement in most patients. The oral lesions of PV 
are usually multiple, typically involving the buccal mucosa and soft palate [24, 26]. On 
Painful gingiva
Burning sensation
Gingival bleeding
Gingival erythema not resulting from dental plaque accumulation
Desquamation, erosion, and ulceration of the gingiva
Blister formation on the gingiva
Other intraoral and/or extraoral lesions
Possible positive Nikolsky’s sign of the gingiva
Modified from Endo et al. [6, 17], Rees & Burkhart [3].
Table 1. 
Clinical appearance of desquamative gingivitis.
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occasion, the gingiva is the only site involved, and DG is a relatively common clinical 
manifestation of the disease [27, 28]. It has been determined that the principal autoanti-
gens in pemphigus patients are desmogleins (Dsgs), which are the components of des-
mosomes in the epidermis and mucous membranes [29, 30]. The main target antigen of 
PV is Dsg 3 [29, 30]. Most patients with PV lesions limited to the oral mucosa have only 
anti-Dsg 3 antibody in the serum, whereas patients involving both the oral mucosa and 
skin may have both anti-Dsg 3 and anti-Dsg 1 antibodies [28, 31]. In a histopathologic 
examination, PV is characterized by acantholysis and suprabasilar blister formation in 
the epithelium [3, 10, 12]. In the DIF testing of PV patients, deposition of IgG and C3 is 
often found between the epithelial cells and is characterized by a “fishnet” or “chicken-
wire” pattern [3, 10, 12].
In addition to the classic DG lesions, clinical diagnosis for MMP or PV may be 
supported by the presence of extragingival lesions including the buccal mucosa, 
the soft palate or tongue, or the presence of extraoral lesions including the eyes, 
upper respiratory tract, genitals, anus, or skin [3, 17, 31]. However, the patients 
often had lesions confined only to the gingiva [27]. In such a case, early diagnosis 
of autoimmune bullous diseases in the oral cavity may become more difficult. 
Diagnosis delays of more than 6 months were experienced by 30.8% of this group of 
PV patients and 54.2% of the MMP patients [27]. 16.7% of patients with MMP were 
delayed for more than 12 months from onset to diagnosis [27].
Epithelial desquamation of the gingiva is a prominent clinical feature that 
supports early clinical diagnosis of autoimmune bullous diseases in the oral cavity 
[6]. Some of the patients with MMP or PV were aware of painful epithelial des-
quamation of the gingiva during meals or oral hygiene practices, and the patients 
complained it to the dental practitioners. However, due to the limited understand-
ing of oral healthcare providers for autoimmune bullous diseases, MMP or PV was 
not included in the differential diagnosis [6]. For that reason, many patients are 
not diagnosed until lesions have become severe. Early diagnosis of MMP or PV 
is critical for proper management and prevention of potential serious complica-
tions. Nikolsky’s sign is a phenomenon characterized by epithelial desquamation 
as a result of slight pressure or rubbing the skin or oral mucosa [32]. This sign is a 
simple test that can confirm the existence of gingival desquamation. In the dental 
clinic, the presence of Nikolsky’s sign can be evaluated by the application of a firm 
sliding or rubbing force to the mucosal surface using a dental instrument [3, 32]. 
In an attempt to facilitate the recognition of the early symptoms of autoimmune 
bullous diseases, the purpose of this study was to examine the frequency of positive 
Nikolsky’s sign at the first visit in patients with MMP or PV. Results of this study 
may expedite the diagnosis of autoimmune bullous diseases developing in the oral 
cavity.
The most frequent diseases or disorders
Oral lichen planus
Mucous membrane pemphigoid
Pemphigus vulgaris
Hypersensitivity reactions to dental hygiene products, food flavorings, or preservatives
Other rare conditions*
*A variety of other potential causes such as lupus erythematosus, mixed connective tissue disease, graft versus host 
disease, erythema multiforme, epidermolysis bullosa, epidermolysis bullosa acquisita, Kindler syndrome, chronic 
ulcerative stomatitis, lichen planus pemphigoides, plasmacytosis, plasma cell gingivitis, orofacial granulomatosis, 
foreign body granulomas, candidal infection and linear IgA disease, factitious injury of the gingiva, Crohn’s disease, 
psoriasis, sarcoidosis, and adverse drug reactions may possess some but usually not all of the clinical features of 
desquamative gingivitis. Modified from Endo et al. [2, 6], Rees & Burkhart [3].
Table 2. 
Diseases or disorders that are associated with desquamative gingivitis.
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2. Materials and methods
The present study was based on a retrospective review of 39 cases that were 
classified as MMP (25 patients) or PV (14 patients) at Nihon University, School of 
Dentistry at Matsudo, from 2001 to 2018. The protocol of this study was approved 
by an institutional review board (Ethics Committee Approval No. EC14-011-1). The 
summary of the 39 patients are shown in Table 3. Some of the 39 patients presented 
in this study have been previously reported [6, 10, 11, 14, 27, 28, 31]. All 39 patients 
described gingival lesions consistent with DG (Figures 1 and 2). The oral lesions 
were confined to the gingiva in 27 patients (69.2%), although other 12 patients 
(30.8%) also had extragingival involvements (the buccal mucosa, soft palate, or 
tongue). Eleven of the 39 patients (28.2%) confirmed the existence of extraoral 
involvements (nose, pharynx, larynx, ocular mucosa, or skin). Gingival biopsies 
were performed in all 39 patients. Patients were diagnosed with MMP or PV through 
clinical examination supported by histopathologic diagnosis and DIF testing for each 
patient (Figures 3 and 4). The current study examined the clinical records of each 
MMP (n = 25) PV (n = 14) Total 
(n = 39)
Age at diagnosis
Mean (years) 65.8 46.9 59.0
Range (years) 36–80 24–73 24–80
Gender
Male 9 1 10 (25.6%)
Female 16 13 29 (74.4%)
Clinical findings
Desquamative gingivitis 25 14 39 (100%)
Intraoral site involvement
Restricted to the gingiva 18 9 27 (69.2%)
Gingiva + extragingiva 7 5 12 (30.8%)
Extraoral site involvement* 8 3 11 (28.2%)
Biopsy findings
Histopathological examination
Subepithelial blisters 21 —
Acantholysis and suprabasilar blisters — 14
Nonspecific 3 —
Nondiagnostic 1 —
DIF examination
BMZ deposition** 25 —
ICS deposition** — 14
MMP = mucous membrane pemphigoid; PV = pemphigus vulgaris; DIF = direct immunofluorescence; 
BMZ = basement membrane zone; ISC = intercellular space.
*After a diagnosis of MMP or PV, patients were advised to confirm the presence or absence of extraoral lesions by a 
dermatologist, an otorhinolaryngologist, and an ophthalmologist.
**Deposition of varying combinations of IgG, IgA, fibrinogen, and complement C3.
Table 3. 
Characteristics of 39 patients with autoimmune bullous diseases.
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Figure 1. 
Desquamative gingivitis in mucous membrane pemphigoid. The intensity of the gingival erythema or erosion is 
variable, and the involvement may be diffuse or patchy distribution.
Figure 2. 
Desquamative gingivitis in pemphigus vulgaris. The attached gingiva presents as friable nature of the tissue. 
Bullae develop quickly and then rupture, leaving eroded painful surfaces with ragged borders.
Figure 3. 
Biopsy confirmation of mucous membrane pemphigoid. A subepithelial blister formation was found in 
hematoxylin-eosin-stained section. Direct immunofluorescence showed a linear deposition of IgG at the 
basement membrane zone.
Figure 4. 
Biopsy confirmation of pemphigus vulgaris. Acantholysis and suprabasilar blister formation were recognized in 
hematoxylin-eosin-stained section. Direct immunofluorescence showed an intercellular deposition of IgG.
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individual which provided information on each patient’s gingival symptoms, gingival 
site involvement, and the presence of gingival epithelial desquamation based on a 
test for Nikolsky’s sign. At the initial dental appointment, a test for Nikolsky’s sign 
was performed in all 39 patients by a single examiner (HE) using the “marginal” 
method and the “direct” method (Figures 5 and 6) [32, 33]. Briefly, a positive 
gingival Nikolsky’s sign described the extension of the erosion on the surrounding 
normal-appearing tissue by rubbing the edge of the affected area with a periodontal 
probe (the “marginal” method), or the ease of inducing erosion by rubbing appar-
ently unaffected the gingiva distant from the lesions (the “direct” method). All 39 
patients were evaluated using the “marginal” method. In addition, in some patients 
we also used the “direct” method. When a positive Nikolsky’s sign was identified, the 
presence of gingival bleeding was also evaluated (Figure 6).
3. Results
Table 4 summarizes the gingival symptoms in the 39 patients. Clinical symp-
toms described were soreness (31 patients, 79.5%), bleeding (21 patients, 53.8%), 
and swelling (18 patients, 46.2%). The results summarizing the gingival site 
involvement are shown in Table 5. The sites where DG lesions were most frequently 
found were the anterior areas (35 patients, 89.7%). In contrast, only four patients 
(10.3%) had DG lesions confined to the molar areas. Most of the gingival involve-
ment was observed in the labial/buccal area (37 patients, 94.7%). In 22 patients 
(56.4%), gingival involvement was also observed in the palatal/lingual area. A 
positive Nikolsky’s sign was demonstrated in 38 of the 39 patients (97.4%) at the 
first visit (Table 6). In 16 of the 38 patients (42.1%) in association with positive 
Figure 5. 
Nikolsky’s sign in pemphigus vulgaris. The epithelium is dislodged by the application of a firm sliding force.
Figure 6. 
Nikolsky’s sign with bleeding in mucous membrane pemphigoid. Gingival bleeding can occur in some patients 
characterized by subepithelial blister formation.
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Nikolsky’s sign, gingival bleeding was induced by gentle pressure (Table 7). All 16 
patients were subsequently diagnosed as having MMP (Table 7).
4. Discussion
In this study, 39 DG patients with autoimmune bullous diseases diagnosed 
as MMP or PV participated. All the patients complained of gingival soreness, 
bleeding, and/or swelling (Table 4). A positive reaction showing Nikolsky’s sign 
was confirmed in 38 patients (97.4%) at their first visit (Table 6). This result 
indicates that it is important to evaluate the presence of gingival Nikolsky’s sign 
in DG patients. Patients showing positive Nikolsky’s sign should have MMP or PV 
included in the differential diagnosis when DG is identified. However, it should be 
noted that it is critical to conduct DIF biopsy testing in addition to histopathologi-
cal examination. By doing this, the oral healthcare providers can contribute to 
the early diagnosis and treatment for MMP or PV lesions in the oral cavity. It is 
MMP (n = 25) PV (n = 14) Total (n = 39)
Soreness 17 14 31 (79.5%)
Bleeding 16 5 21 (53.8%)
Swelling 14 4 18 (46.2%)
Table 4. 
Gingival symptoms.
MMP (n = 25) PV (n = 14) Total (n = 39)
Anterior gingiva 22 13 35 (89.7%)
Restricted to the molar gingiva 3 1 4 (10.3%)
Labial/buccal gingiva 24 13 37 (94.9%)
Palatal/lingual gingiva 14 8 22 (56.4%)
Table 5. 
Gingival site involvement.
MMP (n = 25) PV (n = 14) Total (n = 39)
Positive 24 14 38 (97.4%)
Negative 1 0 1 (2.6%)
Table 6. 
Gingival Nikolsky’s sign at the first visit.
MMP (n = 24) PV (n = 14) Total (n = 38)
With gingival bleeding 16 0 16 (42.1%)
Without gingival bleeding 8 14 22 (57.9%)
Table 7. 
Positive Nikolsky’s sign with or without gingival bleeding.
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important to note, however, that DG sites should not be selected for biopsy diag-
nosis since intact epithelium is necessary to confirm the diagnosis of these autoim-
mune disorders [3, 10]. This retrospective study was limited to those who exhibited 
autoimmune bullous diseases, and consequently we do not know the nature or 
number of diseases causing DG in individuals with other disorders. Another 
limitation of this study is that it does not include a control group. Future controlled 
clinical studies, including the test in non-autoimmune diseases groups, are needed 
to establish the validity of the results of the present study.
This study found that the gingiva is a preferable site for performing a test for 
Nikolsky’s sign. The site where DG lesions were frequently found was the anterior 
area of 35 patients (89.7%), while 37 patients (94.7%) were identified to have DG on 
either labial or buccal gingiva (Table 5). This indicates that direct access to the gin-
gival surface to be examined is easy. The most suitable site for a test for Nikolsky’s 
sign would be the labial gingiva of the anterior area of the upper and lower jaws. In 
evaluating Nikolsky’s sign, the presence of bleeding from the gingiva roughly guess 
which epithelial cleavage level is occurring (subepithelial separation or intraepi-
thelial separation). If the gingival bleeding occurred after performing a Nikolsky’s 
sign, this would imply a subepithelial separation such as MMP. In contrast, if the 
gingival bleeding was unlikely to occur, this would imply an intraepithelial separa-
tion such as PV. In this study, 16 patients (42.1%) had bleeding after application of 
a sliding or rubbing force on the gingiva, and all of 16 patients diagnosed as having 
MMP (Table 7). It should be noted, however, that the presence of gingival bleed-
ing is also affected by the magnitude of the sliding or rubbing force to the gingival 
surface and the degree of gingival inflammation caused by concomitant dental 
plaque-induced gingivitis.
The classic Nikolsky’s sign seen on the skin was first described by Piotr 
Vasiliyevich Nikolskiy who was a Russian dermatologist [33]. Presently, “Nikolskiy” 
and “Nikolsky” are synonyms in the English literature [32, 33]. Nikolsky’s sign that 
was originally defined by Nikolskiy is a characteristic of skin lesions in pemphigus 
foliaceus [34]. Many experts, however, now agree that Nikolsky’s sign is elicited by 
several mucocutaneous disorders, as well as the pemphigus group [32–37]. Grando 
et al. [33] described two modifications of Nikolsky’s sign, the “marginal” method 
that is performed on the edge of an active skin lesion and the “direct” method that 
is on an area of apparently unaffected skin distant from the lesions. The “direct” 
Nikolsky’s sign is a phenomenon that occurs when an immunological disorder has 
been implicated such as in pemphigus [38]. This finding supports the concept that 
immune deposits in autoimmune bullous diseases may be present in outwardly 
normal-appearing tissue. Sheklakov, another Russian dermatologist, first reported 
the ability to elicit Nikolsky’s sign in the oral mucosa [33]. This phenomenon is 
very common in MMP or PV patients with lesions in the oral mucosa as shown in 
this study. Other autoimmune bullous diseases such as bullous pemphigoid, lichen 
planus pemphigoides, and paraneoplastic pemphigus show a positive Nikolsky’s 
sign in the mouth although the number of patients is small [32, 39]. In addition, 
there are a number of other non-autoimmune diseases or disorders associated 
with positive Nikolsky’s sign on the oral mucosa [32, 35]. Oral lichen planus is a 
chronic inflammatory mucocutaneous disease caused by an unknown etiology. 
A possible autoimmune etiology has been suggested but not yet confirmed in 
lichen planus. Nonetheless, a positive Nikolsky’s sign sometimes was identified in 
patients with erosive oral lichen planus (Figure 7) [40, 41]. Histopathologically, 
oral lichen planus is characterized by band-like lymphocyte infiltration below the 
epithelium and basal cell liquefaction [40, 42]. The basal cell liquefaction may 
cause the epithelial separation from underlying connective tissue, especially if 
traumatic forces are present [3]. Positive DIF findings are only considered to be 
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supportive but not diagnostic for oral lichen planus [3]. Erythema multiforme is a 
rare, acute reactive disorder that can affect the skin and mucous membranes. The 
clinical appearance of oral lesions may present as diffuse erythema, bulla, erosions, 
and ulcerations with or without pseudomembrane [43, 44]. The vermilion border 
of the lips is often involved. Nikolsky’s sign of the gingiva has occasionally been 
described (Figure 8) [32]. The diagnosis of oral erythema multiforme is often dif-
ficult because the clinical features may mimic other oral inflammatory and vesicu-
lobullous diseases or disorders. The diagnosis is usually supported by biopsy and 
exclusion of other causes [43, 44]. On rare occasions, gingival lesions caused by 
Figure 7. 
Desquamative gingivitis in erosive oral lichen planus. Localized erythematous lesions were found in the 
attached gingiva. The “marginal” Nikolsky’s sign showed a positive reaction. The histopathological findings 
indicated band-like lymphocyte infiltration below the epithelium and basal cell liquefaction.
Figure 8. 
Erythema multiforme with epithelial desquamation. The clinical manifestations of severe oral ulceration can be 
difficult to differentiate from autoimmune bullous diseases. Histopathological and direct immunofluorescence 
findings were nonspecific. The “marginal” Nikolsky’s sign of the gingiva showed a positive reaction.
Figure 9. 
Gingival injuries caused by excessive toothbrushing. Sharply demarcated abrasions of the gingiva were seen 
and may mimic the “marginal” Nikolsky’s sign elicited by autoimmune bullous diseases. The gingival trauma 
was arrested quickly by making the patients aware that it was caused by incorrect toothbrushing and that it 
could be alleviated by learning correct oral hygiene practices. Their gingival trauma has not recurred since their 
treatment.
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excessive or improper oral hygiene practices or by hypersensitivity reactions to oral 
hygiene products such as toothpaste or mouth rinses may mimic positive Nikolsky’s 
sign elicited by autoimmune bullous diseases (Figure 9) [45–47]. Biopsy may 
provide histopathologic evidence supporting the diagnosis, but DIF is often not 
indicated because it is routinely negative since intact epithelium may be required 
to validate the diagnosis. Eliminating causative agents leads to disappearance of 
gingival involvement in most patients with hypersensitivity reactions to dental or 
dental hygiene products.
After the diagnosis of MMP or PV, patients often require an extraoral examina-
tion by medical specialists including a dermatologist, an ophthalmologist, and 
an otolaryngologist. All patients with extraoral involvement should be managed 
by medical specialists using systemic treatment with or without hospitalization. 
Patients with exclusively oral lesions may be managed using moderate to very-high-
potency topical corticosteroid therapy often combined with effective dental plaque 
control. The therapeutic goal for DG lesions is the remission or suppression of the 
clinical signs and symptoms such as gingival soreness, bleeding, and swelling as 
shown in Table 4. Response to therapy can be assessed to determine whether or not 
the patient exhibits a positive Nikolsky’s sign or other evidence of ongoing disease. 
The disappearance of lesions and of Nikolsky’s sign may indicate a favorable treat-
ment outcome.
5. Conclusions
Nikolsky’s sign is a simple nondiagnostic test that may suggest a need for 
biopsy diagnosis of autoimmune or other diseases in the oral mucosa. The gingiva 
is often a preferable site for performing the test for Nikolsky’s sign especially if 
DG is present. A positive reaction of this sign is the basis for suspecting autoim-
mune bullous diseases such as MMP and PV. In that case, it is critical to conduct 
DIF testing in conjunction with histopathological examination to establish the 
final diagnosis. It is also important to remember that DG is a general descriptive 
term rather than a diagnosis. Oral healthcare providers have a great responsibility 
to remain suspicious of unexplained oral manifestations of systemic or unusual 
intraoral diseases and disorders. The presence of a positive oral Nikolsky’s sign 
serves as a warning that careful evaluation is needed in search of the etiology of 
the sign. Once other causes have been eliminated, the clinician must remain aware 
that biopsy or referral for biopsy may be necessary to determine the current diag-
nosis. It is important to remember, however, that biopsy of tissue sites that feature 
Nikolsky’s sign is not indicated because a positive Nikolsky’s sign is indicative of 
friable epithelium and proper diagnosis is predicated on obtaining a biopsy from 
a site with intact epithelial surfaces. Nonetheless, this simple test for Nikolsky’s 
sign may serve as a valuable indicator of underlying autoimmune or other diseases 
and lead to obtaining a correct diagnosis. In many instances patients with diseases 
or disorders featuring gingival Nikolsky’s sign may require appropriate referral 
to other dental or medical specialists after identifying suspicious lesions. For the 
early diagnosis of autoimmune bullous disorders, oral healthcare providers should 
consider the use of this test that may ultimately lead to the early diagnosis of MMP 
and PV or other diseases or disorders.
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